COVID-19 Vaccines/adverse effects

Schultze, A. ., Martin, I. ., Messina, D. ., Bots, S. ., Belitser, S. ., Carreras-Martínez, J. ., … Douglas, I. . (2024). A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases. Vaccine, 42, 3039–3048. http://doi.org/10.1016/j.vaccine.2024.03.043
Burn, E. ., Li, X. ., Kostka, K. ., Stewart, H. M., Reich, C. ., Seager, S. ., … Prieto-Alhambra, D. . (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495–510. http://doi.org/10.1002/pds.5419